Ariadna Bargiela, Natalia Riedel, Jorge Espinosa Espinosa, Dulce Peris Moreno, Manuel Pérez Alonso, Rubén Artero (2024). Desarrollo preclínico de oligonucleótidos silenciadores de MSI2 en distrofia miotónica. (Communication). XVII Reunión anual del CIBERER 2024 . El Escorial . SPAIN
Ariadna Bargiela; Rubén Artero (2024). Promoting meaningful learning through the acquisition of competencies by using an electronic laboratory notebook. (Communication). 6th International 'ARTEMİS' Congress on Health and Sports Sciences . Izmir . TURKEY
Maria Sabater-Arcís; Nerea Moreno; Ariadna Bargiela; David Seoane-Miraz; Mathew Wood; Miguel Varela; Jorge Espinosa-Espinosa; Ruben Artero; Manuel Pérez-Alonso (2024). Mutant DMPK transcripts interacts with miR-107 triggering the MSI2>mir-7>autophagy axis in myotonic dystrophy. (Communication). IDMC-14 . Nijmegen . NETHERLANDS
Javier Poyatos-García; Alicia Novella; Marta casado; Carme Cucarella; Juan J Vilchez; Ariadna Bargiela; Rubén Artero (2024). Caracterización y retos de un modelo murino de LGMDD2. (Poster). XVII Reunión Anual del CIBERER 2024 . El Escorial . SPAIN
Rubén Artero; Arturo López-Castel; Raquel Pérez-Gómez; Monica Suelves; Gisela Nogales; Andrea López-Martínez: Virginia Arechavala-Gomeza; Juan M Fernández-Costa; Javier Ramón; Inmaculada Azorín; Nuria Muelas; Carme Fàbrega; Ramón Eritja; Sonia Alonso-Martín; Adolfo López de Munain (2024). RED-DM, the Spanish National Network on Myotonic Dystrophy. (Poster). The 14th International Myotonic Dystrophy Consortium Meeting (IDMC-14) . NETHERLANDS
I González-Martínez; E Cerro-Herreros; N Moreno-Cervera; Marieke Willemse; Sarah Overby; Walther J.A.A. van den Broek; Derick G. Wansink; B Llamusí; R Artero (2024). Novel antagomiRs that upregulate MBNL1 as candidate therapies for Myotonic dystrophy. (Poster). IDMC-14 . NETHERLANDS
G. Menduti; C. Januel; C. Ruatti; N. Berenger-Currias; P. Konieczny; R. Artero; C. Martinat; M. Boido (2024). Exploiting the drug repositioning strategy for the treatment of Spinal Muscular Atrophy: in vitro and in vivo results of a new effective SMN-dependent molecule. (Poster). 4th Scientific International Congress on Spinal Muscular Atrophy . Ghent . BELGIUM
Ariadna Bargiela, Natalia Riedel, Jorge Espinosa Espinosa, Dulce Peris Moreno, Manuel Pérez Alonso, Rubén Artero (2024). Preclinical development of therapeutic molecules targeting MSI2 in Myotonic Dystrophy. (Poster). International Myotonic Dystrophy Consortium Meeting 14 (IDMC14) . NETHERLANDS
Rubén Artero (2024). Investigación traslacional en miopatías y síndromes neurológicos raros. (Paper). XVII Reunión Anual CIBERER 2024 . El Escorial . SPAIN
María Sabater Arcis; Dulce Peris Moreno; Ariadna Bargiela; Rubén Artero (2024). Boron-containing compounds partially rescue Myotonic Dystrophy type 1 (DM1) molecular signature and phenotype. (Paper). 6th International 'ARTEMIS' Congress on Health and Sports Sciences . Izmir . TURKEY
Paola Dalgo AGUILAR; Rubén ARTERO; Ariadna BARGIELA (2023). Intervention in TNPO3 gene expression in Limb-Girdle Muscular Dystrophy D2 (LGMDD2). (Communication). The 8TH INTERNATIONAL 'BAŞKENT' CONGRESS ON MEDICINE, NURSING, AND HEALTH SCIENCES . Ankara . TURKEY
Andrea García-Rey; Estefanía Cerro-Herreros; Mouli Chakraborty; Nuria Baquero; Isabel Campillo; Irene González-Martínez; Diego Piqueras-Losilla; Isabella Castano; Melanie Nufer; Rubén Artero; Beatriz Llamusí (2023). Lipophilic conjugation ameliorates antimiR PK/PD properties. (Communication). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . SPAIN
Alicia Novella ESTELLÉS; Águeda Blázquez BERNAL; Carme CUCARELLA; Marta CASADO; Ariadna BARGIELA; Rubén ARTERO (2023). Pilot characterization of a LGMDD2 mouse model. (Communication). The 8TH INTERNATIONAL 'BAŞKENT' CONGRESS ON MEDICINE, NURSING, AND HEALTH SCIENCES . Ankara . TURKEY
Natalia Riedel; Ariadna Bargiela Schönbrunn; Rubén Artero; Manuel Pérez Alonso (2023). "Development of gapmers against MSI2, a new therapeutic target against muscle atrophy in myotonic dystrophy type 1". (Poster). Final Meeting COST DARTER Bilbao 2023 . SPAIN
Maria Sabater-Arcís; Nerea Moreno; Ariadna Bargiela; Rubén Artero (2023). Musashi-2 overexpression enhances atrophy phenotypes in vivo by miR-7 repression. (Poster). DARTER COST Action CA17103 Final Meeting - Bilbao . Bilbao . SPAIN
Diego Piqueras-Losilla; Isabel Campillo; Laura Perea-Galera; Sandra López-Domènech; Beatriz Ballester Llobell; Milagros Rocha-Barajas; Maria Jose Roig-Revert; Ester Fernandez-López; Cristina Peris-Martinez; Clara Barbera-Fuset; Aline Huguet-Lachon; Geneviève Gourdon; Rubén Artero; Beatriz Llamusí; Estefanía Cerro-Herreros (2023). Advancing in vivo modeling and delivery systems for triplet repeat expansion-mediated corneal endothelial dystrophy: Implications in AntimiR therapy. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . SPAIN
Isabella Castano; Argimiro Mayoral; Isabel Campillo; Diego Piqueras-Losilla; Nuria Barquero; Andrea García-Rey; Melanie Nufer; Lara Milián; Manuel Mata; María Sancho-Tello; Mauro Llop; Rubén Artero; Beatriz Llamusí; Estefanía Cerro-Herreros (2023). Effect of K2210 on a knee osteoarthritis rat model. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . SPAIN
Beatriz Llamusí; Diego Piqueras Losilla; Isabel Campillo; Andrea Garcia Rey; Melanie Nufer; Nuria Barquero; Aline Huguet; Geneviève Gourdon; Ruben Artero; Estefanía Cerro Herreros (2023). Systemic treatment with a lipophilic conjugated antimiR 23b rescues functional and molecular phenotypes of DM1 cognitive dysfunction in DMSXL mice. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . SPAIN
Estefanía Cerro-Herreros; Andrea García-Rey; Irene González-Martínez; Mouli Chakraborty; Nuria Barquero Barquero; Diego Piqueras; Isabella Castano; Melanie Nufer; Isabel Campillo; Anna Colom-Rodrigo; Marc Carrascosa-Sàez; Nerea Moreno-Cervera; Beatriz Llamusi; Rubén Artero (2023). Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . Barcelona . SPAIN
Natalia Riedel, Ariadna Bargiela Schönbrunn, Maria Sabater-Arcís, Jorge Espinosa, Rubén Artero, Manuel Pérez Alonso (2023). Preclinical development of gapmers against a new therapeutic target in Myotonic Dystrophy. (Poster). 19th Annual Meeting of the Oligonucleotide Therapeutics Society . SPAIN
Giovanna Menduti; Camille Januel; Cristina Ruatti; Noémie Berenger-Currias; Cecile Martinat; Rubén Artero; Piotr Konieczny; Marina Boido. (2023). Uncovering repositioned therapies' efficacy for Spinal Muscular Atrophy treatment. (Paper). 20th National Congress of the Italian Society for Neuroscience . Turin . ITALY
Maria Sabater-Arcis;Nerea Moreno; Ariadna Bargiela; Rubén Artero (2023). MUSASHI-2 OVEREXPRESSION ENHANCE MUSCLE DYSFUNCTION IN MYOTONIC DYSTROPHY TYPE 1 BY THE REPRESSION OF MIR-7 BIOGENESIS. (Paper). The 8TH INTERNATIONAL 'BAŞKENT' CONGRESS ON MEDICINE, NURSING, AND HEALTH SCIENCES . Ankara . TURKEY
Nerea Moreno; Maria Sabater-Arcís; Ariadna Bargiela; Rubén Artero (2023). OLEIC ACID TREATMENT IN MYOTONIC DYSTROPHY TYPE 1 MUSCLE CELLS IMPROVES MUSCLE DYSFUNCTION PHENOTYPES. (Paper). The 8TH INTERNATIONAL 'BAŞKENT' CONGRESS ON MEDICINE, NURSING, AND HEALTH SCIENCES . Ankara . TURKEY
Ariadna Bariela Schönbrunn; Manuel Pérez Alonso; Rubén Artero (2022). Fomentar el aprendizaje significativo mediante la adquisición de competencias por medio del uso de un cuaderno de laboratorio electrónico. (Communication). Congreso Internacional de Innovación Educativa en Educación Superior . Bilbao . SPAIN
Andrea García-Rey; Estefanía Cerro-Herreros; Judit Núñez-Manchón; Neia Naldaiz-Gastes; Marc Carrascosa-Sàez, Irene González-Martínez; Javier Poyatos-García; Juan J Vilchez; Adolfo López de Munain; Mònica Suelves; Gisela Nogales-Gadea; Beatriz Llamusí; Rubén Artero (2022). AntimiR-23b based therapy rescues MBNL1-dependent splicing patterns in a range of Myotonic Dystrophy genetic backgrounds. (Poster). ConBioPreVal. Congreso Nacional de Jóvenes Investigadores en Biomedicina . Valencia . SPAIN
Anna Colom-Rodrigo; Irene González-Martínez; Arturo López-Castel; Estefanía Cerro-Herreros; Ruben Artero (2022). Involvement of miR-23b and miR-218 in the pathogenesis of Myotonic Dystrophy type 1. (Poster). ConBioPreVal. Congreso Nacional de Jóvenes Investigadores en Biomedicina . Valencia . SPAIN
Javier Poyatos-Garcia; Águeda Blázquez-Bernal; Marta Selva-Giménez; Ariadna Bargiela; Rafael P. Vázquez-Manrique; Anne Bigot; Ruben Artero; Juan Jesús Vilchez (2022). TNPO3 c.2771delA edition by CRISPR-Cas9 in a muscle cell model of Limb-Girdle Muscular Dystrophy type D2. (Poster). 7th International Myology Congress . Nice . FRANCE
I González Martínez; E Cerro Herreros; N Moreno Cervera; A García Rey; M Carrascosa Saez; A Arzumanov; D Seoane; M Fischer; Y Jad; R Raz; MA Varela; MJ Wood; B Llamusi; R Artero (2022). Peptide conjugated antimiRs rescue Myotonic Dystrophy phenotypes in animal and cell models by promoting MBNL1 expression. (Poster). International Myotonic Dystrophy Consortium Meeting 13 (IDMC-13) . Osaka . JAPAN
M Sabater Arcís; N Moreno; A Bargiela; R Artero (2022). Musashi-2 overexpression contributes to myotonic dystrophy muscle dysfunction by the repression of miR-7 biogenesis. (Poster). International Myotonic Dystrophy Consortium Meeting 13 (IDMC-13) . Osaka . JAPAN
Estefanía Cerro-Herreros; Judit Núñez-Manchón; Neia Naldaiz-Gastesi; Marc Carrascosa-Sàez; Andrea García-Rey; Irene González-Martínez; Kevin Moreno; Javier Poyatos-García; Juan J Vilchez; Adolfo López de Munain; Mònica Suelves; Gisela Nogales-Gadea; Beatriz Llamusí; Rubén Artero (2022). Lead antimiR-23b drug rescues cell phenotypes in a range of Myotonic Dystrophy genetic backgrounds. (Poster). 2022 Myotonic Dystrophy Foundation (MDF) Annual Conference . San Diego . UNITED STATES
Nerea Moreno, Maria Sabater-Arcis, Ariadna Bargiela, Ruben Artero (2022). Musashi-2 overexpression enhances atrophy phenotypes in vivo by miR-7 repression. (Poster). 1st FEBS-IUBMB-ENABLE International Molecular Biosciences PhD and Postdoc Conference entitled "The perfect tandem: How technology expands the frontiers of biomedicine' . Sevilla . SPAIN
Natalia Riedel; Ariadna Bargiela Schönbrunn; Rubén Artero; Manuel Pérez Alonso (2022). "Development of gapmers against MSI2, a new therapeutic target against muscle atrophy in myotonic dystrophy type 1". (Poster). 1st FEBS-IUBMB-ENABLE International Molecular Biosciences PhD and Postdoc Conference . Sevilla . SPAIN
Marta SELVA-GIMÉNEZ; Javier POYATOS-GARCIA; Águeda BLÁZQUEZ-BERNAL; Ariadna BARGIELA; Jorge ESPINOSA-ESPINOSA; Rafael P. VÁZQUEZ-MANRIQUE; Anne BIGOT; Ruben ARTERO; Juan Jesús VILCHEZ (2022). CRISPR-Cas9 editing of the TNPO3 mutation causing Limb-Girdle Muscular Dystrophy type D2 in a muscle cell model. (Paper). VIII. International Istambul Scientific Research Congress . Estambul . TURKEY
Ariadna BARGIELA; Amadeo TEN; Luis Marti BONMATI; Teresa SEVILLA; Ruben ARTERO (2022). In vivo study of muscle dysfunction in myotonic dystrophy mice by quantitative nuclear magnetic resonance imaging. (Paper). VIII. International Istambul Scientific Research Congress . Estambul . TURKEY
Agueda Blázquez, Javier Poyatos, Marta Selva, Juan Vílchez, Ruben Artero, Ariadna Bargiela (2022). CRISPR-Cas9 EDITING OF TNPO3 MUTATION IN THE FIRST CELL MODEL OF Limb-Girdle MUSCULAR DYSTROPHY TYPE D2. (Paper). 5TH INTERNATIONAL CONGRESS ON LIFE, SOCIAL, AND HEALTH SCIENCES IN A CHANGING WORLD . TURKEY
J Espinosa Espinosa; E. Cerro Herreros; I González Martínez; N Moreno; SJ Overby; B Llamusi; Ruben Artero (2022). Comprehensive transcriptomic characterization of antisense RNA treatments effects on Myotonic dystrophy type 1 cell models. (Paper). International Myotonic Dystrophy Consortium Meeting 13 (IDMC-13) . Osaka . JAPAN
Ariadna Bargiela; Amadeo Ten; Luis Martí Bonmatí; Teresa Sevilla; Rubén Artero (2022). Quantitative nuclear magnetic resonance imaging, a tool for in vivo study of muscle dysfunction in myotonic dystrophy model mice. (Paper). V International New York Academic Research Congress. Online . New York . UNITED STATES
Águeda Blázquez-Bernal; Javier Poyatos-Garcia; Marta Selva-Gimenez; Ariadna Bargiela; Juan J. Vilchez; Ruben Artero (2021). Characterization of cell model of LGMDD2 and validation of candidate therapies. (Communication). V International LGMD1F-D2 Congress . SPAIN
Carlos Casillas-Serra; Estela Selma-Soriano; Ruben Artero; Juan Antonio Navarro; Josep Redón (2021). Rabphilin silencing causes dilated cardiomyopathy in a Drosophila´s human model of cardiac-nephrocyte damage. (Poster). Sociedad Española de Genética . SPAIN
Águeda Blázquez Bernal; Juan M. Fernandez Costa; Ariadna Bargiela; Ruben Artero (2021). Development of a Drosophila model of LGMD1F and drug screening. (Poster). 62nd Annual Drosophila Research Conference . UNITED STATES
Beatriz Llamusi, Ruben Artero, Estefania Cerro-Herreros, Irene González-Martinez, Nerea Moreno-Cervera, Sarah Overby, Manuel Perez-Alonso (2021). Development of an antimiR-based treatment against Myotonic Dystrophy disease. (Poster). Noncoding RNA World: From Mechanism to Therapy . SWITZERLAND
Bargiela, Ariadna; Sabater-Arcis, Maria, and Artero, Ruben (2021). Repression of miR-7 by Musashi-2 leads to increased autophagy and muscle dysfunction in myotonic dystrophy type 1. (Poster). New Directions in Biology and Disease of Skeletal Muscle Conference . Charleston . UNITED STATES
Ariadna Bargiela , Maria Sabater, Ruben Artero (2021). Contribution of Musashi-2 to muscle dysfunction in myotonic dystrophy by upregulating autophagy through miR-7 biogenesis repression. (Poster). Noncoding RNA World: From Mechanism to Therapy . SWITZERLAND
Giovanna Menduti, Piotr Konieczny, Camille Januel, Cecile Martinat, Ruben Artero, Marina Boido (2021). Drug repositioning strategy in Spinal Muscular Atrophy: therapeutic effects of the antibiotic Moxifloxacin in SMNΔ7 mice. (Poster). 4th Brainstorming Research Assembly for Young Neuroscientists . Pisa . ITALY
Sarah Overby; Estefanía Cerro-Herreros, Irene González-Martínez, Miguel Varela, Matthew Wood, Beatriz Llamusí, Ruben Artero (2021). BlockmiR induced MBNL rescue in DM1 models. (Poster). Oligonucleotide Therapeutics Society Annual Meeting . Virtual . UNITED STATES
Sabater-Arcis M; Bargiela A; Furling D; Artero R (2021). Effects of miR-7 modulation on muscle atrophy-related phenotypes in myotonic dystrophy. (Invited paper). RNAi 2021 . Oxford (Online) . UNITED KINGDOM
Águeda Blázquez-Bernal; Ariadna Bargiela; Rubén Artero, (2020). Development of a Drosophila model of LGMD1F, an ultra-rare genetic disease that protects against HIV. (Communication). IV Congreso Nacional de Jóvenes Investigadores en Biomedicina . SPAIN
Beatriz Llamusi, Estefania Cerro-Herreros, Irene González-Martínez, Nerea Moreno-Cervera, Sarah Overby, Manuel Pérez-Alonso, Rubén Artero (2020). Therapeutic potential of antagomiR-23b for treating Myotonic Dystrophy. (Communication). 16th Annual Meeting of the Oligonucleotide Therapeutics Society . UNITED STATES
Sarah Overby, Estefania Cerro-Herreros, Beatriz Llamusi, Ruben Artero (2020). Proof of concept of blockmiR induced MBNL rescue in DM1 models. (Communication). 16th Annual Meeting of the Oligonucleotide Therapeutics Society . UNITED STATES
Piotr Konieczny; Rubén Artero (2020). From flies to mice: evaluation of combinatorial therapy for SMA. (Communication). Motor Neuron Diseases. Understanding the pathogenetic mechanisms to develop therapies . ITALY